|
Effects of growth hormone-releasing hormone and its agonistic and antagonistic analogs in cancer and non-cancerous cell lines
|
26 December 2013 |
|
Molecular mechanisms of melatonin's inhibitory actions on breast cancers
|
11 December 2013 |
|
Therapeutic actions of melatonin on gastrointestinal cancer development and progression
|
04 December 2013 |
|
All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma
|
03 December 2013 |
|
Inhibitory effect of somatostatin analogue octreotide on the expression of p53 and Ras in human gastric cancer
|
02 December 2013 |
|
New agonist- and antagonist-based treatment approaches for advanced prostate cancer
|
29 November 2013 |
|
Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new therapeutic method for advanced prostate carcinoma
|
29 November 2013 |
|
Treatment of unresectable skull base meningiomas with somatostatin analogs
|
29 November 2013 |
|
Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas
|
27 November 2013 |
|
Place of cabergoline in acromegaly: a meta-analysis
|
27 November 2013 |